Evaluating cost-effectiveness of 9-valent HPV vaccination for men who have sex with men by HIV status in Hong Kong
Our findings support the implementation of 9vHPV vaccination for MSM in Hong Kong, with vaccinating all MSM aged ≥12 years offering the greatest health and economic benefits.
Authors
- David Ka Ki Wong (ORCID: https://orcid.org/0000-0002-3310-3538)
- Wwt Lam (ORCID: https://orcid.org/0000-0003-2383-0149)
- David Makram Bishai (ORCID: https://orcid.org/0000-0003-0714-9062)
- Jianchao Quan (ORCID: https://orcid.org/0000-0002-8386-8512)
- William Chi Wai Wong (ORCID: https://orcid.org/0000-0003-2540-4055)
- Dalsan You (ORCID: https://orcid.org/0009-0000-0408-4254)
- Jiandong Zhou (ORCID: https://orcid.org/0000-0003-3780-9033)
- Karen A. Grépin (ORCID: https://orcid.org/0000-0003-4368-0045)
- Dong‐Bo Wu
- Linda Chan
Institutions
- Education University of Hong Kong (HK)
- HKU-Pasteur Research Pole (HK)
- University of Hong Kong (HK)
Publication Details
- Journal
- Vaccine
- Published
- 2025-08-22
- DOI
- https://doi.org/10.1016/j.vaccine.2025.127625
- Citations
- 1
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 1.35